|
|
Blood, 1 February 2007, Vol. 109, No. 3, pp. 1095-1102.
Prepublished online as a Blood First Edition Paper on September 28, 2006; DOI 10.1182/blood-2006-05-022798.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Annexin-1 modulates T-cell activation and differentiation
Fulvio D'Acquisto1,
Ahmed Merghani1,
Emilio Lecona1,
Guglielmo Rosignoli1,
Karim Raza2,
Christopher D. Buckley2,
Roderick J. Flower1, and
Mauro Perretti1
1 William Harvey Research Institute, Bart's and The London, Queen Mary School of Medicine and Dentistry, Charterhouse Square, London, United Kingdom;
2 Division of Immunity and Infection, MRC Centre for Immune Regulation, University of Birmingham, Edgbaston, United Kingdom
Annexin-1 is an anti-inflammatory protein that plays an important homeostatic role in innate immunity; however, its potential actions in the modulation of adaptive immunity have never been explored. Although inactive by itself, addition of annexin-1 to stimulated T cells augmented anti-CD3/CD28-mediated CD25 and CD69 expression and cell proliferation. This effect was paralleled by increased nuclear factor- B (NF-B), nuclear factor of activated T cells (NFATs), and activator protein-1 (AP-1) activation and preceded by a rapid T-cell receptor (TCR)–induced externalization of the annexin-1 receptor. Interestingly, differentiation of naive T cells in the presence of annexin-1 increased skewing in Th1 cells; in the collagen-induced arthritis model, treatment of mice with annexin-1 during the immunization phase exacerbated signs and symptoms at disease onset. Consistent with these findings, blood CD4+ cells from patients with rheumatoid arthritis showed a marked up-regulation of annexin-1 expression. Together these results demonstrate that annexin-1 is a molecular "tuner" of TCR signaling and suggest this protein might represent a new target for the development of drugs directed to pathologies where an unbalanced Th1/Th2 response or an aberrant activation of T cells is the major etiologic factor.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Huggins, N. Paschalidis, R. J. Flower, M. Perretti, and F. D'Acquisto
Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation
FASEB J,
April 1, 2009;
23(4):
985 - 996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Bosco and P. G. Holt
Genome-wide expression profiling of T-cells in childhood wheeze
Eur. Respir. J.,
November 1, 2008;
32(5):
1138 - 1140.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. Zhu, C. Egelston, A. Vivekanandhan, S. Uematsu, S. Akira, D. M. Klinman, I. M. Belyakov, and J. A. Berzofsky
Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines
PNAS,
October 21, 2008;
105(42):
16260 - 16265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Lecona, J. I. Barrasa, N. Olmo, B. Llorente, J. Turnay, and M. A. Lizarbe
Upregulation of Annexin A1 Expression by Butyrate in Human Colon Adenocarcinoma Cells: Role of p53, NF-Y, and p38 Mitogen-Activated Protein Kinase
Mol. Cell. Biol.,
August 1, 2008;
28(15):
4665 - 4674.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. D'Acquisto, N. Paschalidis, K. Raza, C. D. Buckley, R. J. Flower, and M. Perretti
Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells
Rheumatology,
May 1, 2008;
47(5):
636 - 639.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. A. Swisher, U. Khatri, and G. M. Feldman
Annexin A2 is a soluble mediator of macrophage activation
J. Leukoc. Biol.,
November 1, 2007;
82(5):
1174 - 1184.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
